Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid for Cytogenotoxic Damage in Chronic Drug Users
NCT05712044Unknown
- Sponsor
- Centro Universitario de Tonalá
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label trial of folic acid (2 arms), sponsored by Centro Universitario de Tonalá. Primary endpoints: Micronuclei at 30 days, Binucleated cells at 30 days and 5 more. Status: unknown.
02
Drugs
folic acid
Beyond the preview
Go deeper on NCT05712044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712044.